• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Postmarket surveillance programs largest source of safety data triggering vaccine label changes

bySze Wah Samuel ChanandDeepti Shroff Karhade
July 28, 2020
in Infectious Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Postmarketing surveillance programs of Food and Drug Administration approved vaccines were the most common source of safety data triggering safety label changes.

2. The most common safety label changes included changes in population restrictions and allergies.

Evidence Rating Level: 3 (Average)

Study Rundown: Food and Drug Administration (FDA) approved vaccines undergo postmarket surveillance to identify uncommon and long-term adverse events. For example, the Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program established to monitor approved vaccines. The authors analyzed the initial and approved labels of a cohort of approved infectious disease vaccines to assess postmarket label changes. The most frequent reason for a safety modification was for changes to population restriction, allergies and postvaccination syncope. One vaccine (RotaShield) was withdrawn for safety issues identified through VAERS. The most common source of safety data was postmarketing surveillance. The study highlighted that the majority of vaccine safety label changes were not clinically significant. Moreover, it emphasized the importance of independent monitoring systems in assessing long term complications. However, the study was limited by the availability of public data as not all safety data received by the FDA was included in the study.

Click to read the study, published today in Annals of Internal Medicine

Relevant Reading: Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013

RELATED REPORTS

Approved label populations may be broader than trial populations for new drugs

The 2 Minute Medicine Podcast Episode 54

Reduced pneumococcal vaccine schedules non-inferior to WHO recommendations

In-Depth [retrospective cohort]: In this retrospective cohort study, 57 FDA-approved vaccines were analyzed from 1996 – 2015. The most common approved vaccine was the season influenza vaccine (37%). 58 postapproval label modifications were analyzed. The most common safety issue triggering a label change was increased population restrictions (36%) to include immunocompromised patients, specific preexisting conditions, premature infants and pregnant women. The next most common label change was related to allergies (22%), mostly due to latex packaging. 21% were related to postvaccination syncope. The most common source of safety data was postmarketing surveillance (48%), followed by manufacturer warnings from changes in packaging materials (21%).

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Food and Drug Administration (FDA)immunizationvaccination
Previous Post

A sibling-adoption design for the study of genetic and environmental influence on children’s body mass index #VA

Next Post

Sodium glucose cotransporter-2 inhibitor use associated with increased risk of diabetic ketoacidosis

RelatedReports

A stethoscope intertwined with a compass
Pharma

Approved label populations may be broader than trial populations for new drugs

July 7, 2025
The 2 Minute Medicine Podcast Episode 15
2MM Podcast

The 2 Minute Medicine Podcast Episode 54

March 21, 2025
Compliance-linked incentives increase infant immunizations rates in rural India
Public Health

Reduced pneumococcal vaccine schedules non-inferior to WHO recommendations

December 11, 2024
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Infectious Disease

COVID-19 vaccination and infection not associated with increased risk of congenital anomalies

July 26, 2024
Next Post
Food environment associated with gestational diabetes

Sodium glucose cotransporter-2 inhibitor use associated with increased risk of diabetic ketoacidosis

#VisualAbstract: Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease

#VisualAbstract: Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease

Feasibility of a school-based vision screening program for kindergarten children in Ontario #VA

Feasibility of a school-based vision screening program for kindergarten children in Ontario #VA

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
  • Oral vancomycin may be effective for pouchitis in inflammatory bowel disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.